2 completed, 1 terminated, 1 unknown. 3 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 2, Terminated 1 |
| Phase 1 | 2 | Completed 1, Unknown 1 |
Follow Immune Control: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Fluphenazine in Relapsed or Relapsed-and-Refractory Multiple Myeloma Fluphenazine HCl - Multiple Myeloma | Phase 1 | Unknown | Immune Control | 30 | 2008-12-01 | 2009-01-13 |
| Fluphenazine Hydrochloride for Psoriasis Fluphenazine, Placebo - Psoriasis | Phase 2 | Completed | Tufts Medical Center | 15 | 2008-11-01 | 2017-03-31 |
| Fluphenazine Decanoate for Psoriasis Fluphenazine Decanoate, Placebo - Psoriasis | Phase 2 | Terminated | Tufts Medical Center | 10 | 2006-07-01 | 2010-12-22 |
| Fluphenazine in Treating Patients With Refractory Advanced Multiple Myeloma fluphenazine hydrochloride - Multiple Myeloma and Plasma Cell Neoplasm | Phase 1 / Phase 2 | Completed | Immune Control | 30 | 2006-01-01 | 2013-11-06 |
Multiple Myeloma (2) · Psoriasis (2) · Neoplasms, Plasma Cell (1)
Fluphenazine (3) · fluphenazine depot (1)
United States (4)
Alice B Gottlieb, MD, PhD (1) · Alice B. Gottlieb, M.D., PhD. (1) · Bruce A Silver, M.D., FACP (1)